VKTX

NASDAQ · Biotechnology

Viking Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$33.23

-0.28 (-0.84%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 23 88%

Hold 3 12%

Sell 0 0%

Price Target

Analyst Price Target +105.3% upside

Low Target $46.84

Average Target $68.21

High Target $80.11

Current Price $33.23

Current
$33.23

Target
$68.21

$46.84 $68.21 avg $80.11

Scenario Analysis

Bear Case

$46.84

41.0%

Low target

Base Case

$68.21

+105.3%

Avg target

Bull Case

$80.11

+141.1%

High target

Risk/Reward

3.4x

Highly favorable

Price in Context

52-Week High

$43.15

-23.0% from high

52-Week Low

$22.96

+44.7% from low

50-Day SMA

$32.83

+1.2% vs SMA

200-Day SMA

$31.34

+6.0% vs SMA

RSI (14)

52.7

Neutral

Target vs 52W High

$68.21

+58.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+5.4%
AMGN Amgen Inc	Hold	43	49%	$190.87	-52.7%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+179.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-9.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-42.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-46.0%
BIIB Biogen Inc	Buy	44	64%	$91.45	-55.7%